Toggle navigation
Home
Search
Services
Blog
Contact
About
Rhenium-188 Generator for RE-188 Radioimmunotherapy
Fritzberg, Alan R.
Neorx Corporation, Seattle, WA, United States
Search 17 grants from Alan Fritzberg
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Data and Research Support Center
International Society for Addiction Medicine Annual Conference
Mechanisms of CaM Kinase II signal Transduction
Control of Chondrocyte Differentiation
Chemokines in pathogenesis of Experimental Arthritis
Recently added grants:
Risk of Cognitive Impairment and Dementia in Total Joint Arthroplasty
Global post-transcriptional regulators in P. aeruginosa
Defining Mechanisms of Viral Persistence in Situ at the Single-Cell Level
Pathogenic role of IL-17 response in Streptococcus pneumoniae nasopharyngeal pathogenesis during an influenza virus co-infection
HBV RNaseH inhibitors: Effects on HBV biology and resistance development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067939-001
Application #
3614578
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Rhenium-188 Generator for RE-188 Radioimmunotherapy
Fritzberg, Alan R. / Neorx Corporation
NIH 1986
N43 CM
Rhenium-188 Generator for RE-188 Radioimmunotherapy
Fritzberg, Alan R. / Neorx Corporation
Comments
Be the first to comment on Alan Fritzberg's grant